Others

Parmax Pharma Ltd - Outcome of Board Meeting

| Updated on February 14, 2019 Published on February 14, 2019

Dear Sirs,

This is to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 14th February, 2019, inter-alia, considered and approved the Unaudited Financial Results for quarter and Nine Months ended 31st December, 2018. The same has also been reviewed by the Audit Committee in its meeting held today.

A copy of the Statement of Unaudited Financial Results for the quarter and half year ended 31st December, 2018, approved by the Board pursuant to Regulation 33 of the Securities And Exchange Board of India (LODR Regulations, 2015, is enclosed for your reference and record. A copy thereof has also been sent for publication as per the requirements. The meeting commenced at 1:00 pm. and concluded 4:30 pm.

We would like to submit that M/ s. B A Shah S R Mehta & Co., Statutory Auditors of Company have carried out limited review of Unaudited Financial Results for quarter and Nine Months ended 31st December, 2018 and Board has also taken on record their Limited Review Report on said Results.

Pdf Link: Parmax Pharma Ltd - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on February 14, 2019
This article is closed for comments.
Please Email the Editor